Keith L Ligon

发表

Quantification of aneuploidy in targeted sequencing data using ASCETS

Rameen Beroukhim, Liam F Spurr, Mehdi Touat, 2020, Bioinform..

The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology

Brian M Alexander, Raymond Y Huang, Daniel N Cagney, 2018, Neuro-oncology.

The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas

Catherine L Nutt, Keith L Ligon, David N Louis, 2004, Journal of neuropathology and experimental neurology.

Intermediate DNA methylation is a conserved signature of genome regulation

Ting Wang, Manolis Kellis, Martin Hirst, 2015, Nature Communications.

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

Liliana Goumnerova, Gad Getz, Rameen Beroukhim, 2013, Proceedings of the National Academy of Sciences.

Diffusion-weighted imaging of fungal cerebral infection.

Keith L Ligon, K. Ligon, A. Robicsek, 2005, AJNR. American journal of neuroradiology.

Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.

Tao Sun, Keith L Ligon, David H Rowitch, 2008, Cancer cell.

Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery

Isaiah Norton, Ferenc A Jolesz, Sandro Santagata, 2014, Proceedings of the National Academy of Sciences.

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

Keith L Ligon, Steven J. Greco, Pranela Rameshwar, 2013, Molecular therapy. Nucleic acids.

Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Sandro Santagata, Ziming Du, Jia-Ren Lin, 2018, JCO precision oncology.

A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.

Keith L Ligon, Andrew P McMahon, K. Ligon, 2006, Cancer research.

ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.

Anne E Carpenter, Mark-Anthony Bray, Andrea Califano, 2014, Cell reports.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

Roland Eils, Thomas Zichner, Hans Lehrach, 2013, Nature Genetics.

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Tracy T Batchelor, Volker Hovestadt, Mariella G. Filbin, 2018, Science.

Toward precision medicine in glioblastoma: the promise and the challenges.

Timothy C Ryken, Timothy F Cloughesy, Annette M Molinaro, 2015, Neuro-oncology.

Human glioma growth is controlled by microRNA-10b.

Ming Yi, Thomas Wurdinger, Keith L Ligon, 2011, Cancer research.

MYB-QKI rearrangements in Angiocentric Glioma drive tumorigenicity through a tripartite mechanism

Liliana Goumnerova, Caterina Giannini, Rameen Beroukhim, 2016, Nature Genetics.

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Lorenzo Trippa, Brian M Alexander, Paul S Mischel, 2015, Neuro-oncology.

Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution.

David Twomey, Keith L Ligon, Todd R Golub, 2007, The Journal of molecular diagnostics : JMD.

Emerging insights into the molecular and cellular basis of glioblastoma.

Lynda Chin, William C Hahn, Gavin P Dunn, 2012, Genes & development.

The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Keith L Ligon, Santosh Kesari, David H Rowitch, 2011, Cancer cell.